The typical response of the adult mammalian pulmonary circulation to a low oxygen environment is vasoconstriction and structural remodelling of pulmonary arterioles, leading to chronic elevation of pulmonary artery pressure (pulmonary hypertension) and right ventricular hypertrophy. Some mammals, however, exhibit genetic resistance to hypoxia-induced pulmonary hypertension [1] [2] [3] . We used a congenic breeding program and comparative genomics to exploit this variation in the rat and identified the gene Slc39a12 as a major regulator of hypoxia-induced pulmonary vascular remodelling. Slc39a12 encodes the zinc transporter ZIP12. Here we report that ZIP12 expression is increased in many cell types, including endothelial, smooth muscle and interstitial cells, in the remodelled pulmonary arterioles of rats, cows and humans susceptible to hypoxia-induced pulmonary hypertension. We show that ZIP12 expression in pulmonary vascular smooth muscle cells is hypoxia dependent and that targeted inhibition of ZIP12 inhibits the rise in intracellular labile zinc in hypoxia-exposed pulmonary vascular smooth muscle cells and their proliferation in culture. We demonstrate that genetic disruption of ZIP12 expression attenuates the development of pulmonary hypertension in rats housed in a hypoxic atmosphere. This new and unexpected insight into the fundamental role of a zinc transporter in mammalian pulmonary vascular homeostasis suggests a new drug target for the pharmacological management of pulmonary hypertension.
The typical response of the adult mammalian pulmonary circulation to a low oxygen environment is vasoconstriction and structural remodelling of pulmonary arterioles, leading to chronic elevation of pulmonary artery pressure (pulmonary hypertension) and right ventricular hypertrophy. Some mammals, however, exhibit genetic resistance to hypoxia-induced pulmonary hypertension [1] [2] [3] . We used a congenic breeding program and comparative genomics to exploit this variation in the rat and identified the gene Slc39a12 as a major regulator of hypoxia-induced pulmonary vascular remodelling. Slc39a12 encodes the zinc transporter ZIP12. Here we report that ZIP12 expression is increased in many cell types, including endothelial, smooth muscle and interstitial cells, in the remodelled pulmonary arterioles of rats, cows and humans susceptible to hypoxia-induced pulmonary hypertension. We show that ZIP12 expression in pulmonary vascular smooth muscle cells is hypoxia dependent and that targeted inhibition of ZIP12 inhibits the rise in intracellular labile zinc in hypoxia-exposed pulmonary vascular smooth muscle cells and their proliferation in culture. We demonstrate that genetic disruption of ZIP12 expression attenuates the development of pulmonary hypertension in rats housed in a hypoxic atmosphere. This new and unexpected insight into the fundamental role of a zinc transporter in mammalian pulmonary vascular homeostasis suggests a new drug target for the pharmacological management of pulmonary hypertension.
We have reported previously that the Fisher 344 (F344) rat strain is resistant to hypoxia-induced pulmonary hypertension compared with the Wistar Kyoto (WKY) strain 2 . Linkage analysis of an F 2 population derived from inbred WKY 3 F344 rats identified a quantitative trait locus (QTL) on chromosome 17 (ref. 2) . On the basis of this observation, we next conducted ten successive microsatellite-guided backcrosses of offspring with WKY rats and derived two congenic strains in which the original QTL was dissected and represented as partly overlapping regions of a donor F344 genome interposed onto the genetic background of the WKY recipient strain (Extended Data Figs 1 and 2 ). Resistance to hypoxia-induced pulmonary hypertension was detected in one of the congenic strains (R47A; Fig. 1a-d and Extended Data Fig. 2 ). Three subcongenic strains (SubA, SubB and SubC) were derived by further backcrosses of R47A onto the WKY background and the congenic interval was fine-mapped to a region of 8.28 megabase pairs (Mbp) containing an estimated 65 genes (rat chromosome 17: positions 85,072,475-93,347,784) ( Fig. 1 and Extended Data Fig. 2a ). Whole-genome sequencing (greater than 203 coverage) of the WKY and F344 parental strains 4 revealed 13 non-synonymous coding SNPs affecting 9 genes within the refined congenic interval, and 6 indels resulting in frameshift mutations in 4 genes (Extended Data Table 1 ). Polymorphic examination of the 13 SNPs and 6 indels in 2 additional rat strains susceptible to hypoxia-induced pulmonary hypertension (the spontaneously hypertensive and fawn-hooded rat strains, respectively) excluded 5 SNPs and 5 indels and narrowed the genes of interest to 7 (Slc39a12, St8sia6, Cubn, Nmt2, Dclre1c, Hspa14 and Cdnf; Fig. 1e and Extended Data Table 1 ). Further polyphen analysis allowed us to exclude five listed genes (St8sia6, Cubn, Nmt2, Dclre1c and Cdnf) as the non-synonymous coding changes were predicted to be benign. We identified Slc39a12, with a loss of thymidine at position 88,575,534 leading to a frameshift mutation in exon 11, as the highest priority candidate gene for further investigation.
Slc39a12 encodes the solute carrier 39 zinc transporter family (ZIP1-14) member 12 (ZIP12) and has high specificity for zinc 5 . The ZIP family tightly regulates cellular zinc homeostasis in numerous cell types by promoting zinc uptake from the extracellular space or release from intracellular compartments. The rat Slc39a12 gene contains 12 exons and the ZIP12 protein comprises 688 amino acids with a secondary structure comprising 8 transmembrane domains. In the F344 strain, the frameshift mutation in Slc39a12 introduces a stopcodon predicting a carboxy (C)-terminal truncated ZIP12 protein of 553 amino acids (Extended Data Fig. 3a) . This affects the conserved zinc transporting aqueous cavity between transmembrane domains IV and V, resulting in the loss of the metalloprotease motif (HEXPHE), which would be expected to lead to a reduction in zinc transport 6 . A pathognomonic histological signature of chronic hypoxia-induced pulmonary hypertension is thickening of the pulmonary vascular media (owing to hyperplasia and hypertrophy of smooth muscle cells) and the muscularization of previously unmuscularized pulmonary arterioles 7 . We found that ZIP12 messenger RNA (mRNA) levels were very low and ZIP12 protein was undetectable by immunohistochemistry in the pulmonary vasculature of adult WKY rats housed in a normal oxygen atmosphere, but WKY rats exposed to hypoxia showed markedly increased lung ZIP12 mRNA levels and pronounced ZIP12 expression in remodelled pulmonary arterioles (Fig. 2a, b and Extended Data Fig. 3b ). ZIP12 expression was evident in vascular smooth muscle but also other cell types (endothelial and interstitial cells) known to contribute to structural changes seen in hypoxic lungs. In contrast, and consistent with a frameshift mutation in Slc39a12 predicting a C-terminal truncated protein, ZIP12 was undetectable with an antibody directed at the C terminus of the protein in the lungs of chronically hypoxic F344 rats ( Fig. 2b and Extended Data Fig. 3b ).
Slc39a12 is highly conserved across species 8 and transcribed constitutively in many tissues (http://www.biogps.org). To investigate 
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Figure 2 | Slc39a12 encodes a zinc transporter, ZIP12, which is upregulated in pulmonary vascular tissue from mammals exposed to chronic hypoxia. a, ZIP12 mRNA levels in control and hypoxic WKY rat lungs (n 5 6 per group). b, Prominent ZIP12 immunostaining in remodelled pulmonary arterioles in WKY (red arrows) but not F344 rat lungs exposed to hypoxia. c, No ZIP12 staining was detected in pulmonary arteries of low-altitude (normoxia control, CO calf) calves and sea-level humans, yet prominent ZIP12 immunostaining was observed in the remodelled pulmonary arteries of calves with severe pulmonary hypertension (Hx calf), in cattle naturally susceptible to pulmonary hypertension at altitude ('Brisket disease', BD) as well as Kyrgyz highlanders residing above 2,500 m. d, Design of the luciferase reporter vector pGL4.10 containing a 59 region of ZIP12 that includes an HRE encoding for both HIF-1a-and HIF-2a-binding motifs or a mutant HRE sequence where the 59-ACGTG-39 motif has been replaced by 59-AGCAG-39(mHRE). e, Human pulmonary artery smooth muscle cells (HPASMCs) transfected with the ZIP12 HRE reporter vector demonstrated significantly increased luciferase activity after exposure to hypoxia, but not in the cells transfected with the mutant HRE vector (n 5 6 per group, replicated twice ). f, Increased levels of HIF-1a and HIF-2a bound to the ZIP12 HRE assayed by ChIP-qPCR of chromatin from HPASMCs cultured in normoxia and hypoxic conditions (n 5 3 per group, replicated twice). Data are calculated as the percentage of input levels, with the dotted line marking percentages below mock immunoprecipitation (IP). Values are expressed as mean 6 s.e.m. *P , 0.05, **P , 0.01, ***P , 0.001 compared with normoxic control after one-way ANOVA followed by Bonferroni correction for multiple testing. NS, not significant. LETTER RESEARCH the relevance of our observations in rats to other susceptible animal species, as well as humans, we examined ZIP12 expression in whole lung samples of (1) neonatal calves housed in a normal atmosphere or exposed to hypobaric hypoxia for 2 weeks (barometric pressure 5 445 mm Hg (1 mm Hg 5 133.3 Pa), equivalent to 4,500 m altitude, 12% O 2 ), (2) older (yearling) cattle with naturally occurring pulmonary hypertension (so-called 'Brisket disease') developed as a result of prolonged pasturing at high altitude (2,438-3,505 m) and (3) human subjects at sea level and Kyrgyz highlanders residing above 2,500 m. ZIP12 expression, which is undetectable by immunohistochemistry in healthy bovine and human lung exposed to a normal oxygen atmosphere (Fig. 2c) , was clearly visible in the remodelled pulmonary vessels from chronic hypoxia exposure, indicating that ZIP12 upregulation in pulmonary vasculature is a common response to hypoxia (Fig. 2c) .
To better understand the regulation of ZIP12 by hypoxia, we exposed human pulmonary vascular smooth muscle cells in culture to hypoxia (2% O 2 ). Increased hypoxia-inducible factor (HIF) protein and ZIP12 gene expression was observed in hypoxic cells; mRNA levels of other zinc transporters, ZIP6, ZIP7, ZIP10 and ZnT8, were unchanged (Extended Data Fig. 4a, b) . Further examination of the Slc39a12 gene using HOMER analysis 9 revealed a hypoxia response element (HRE) encoding both HIF-1a-and HIF-2a-binding motifs (Fig. 2d ) located 1 kb downstream of the ZIP12 transcription start site (human (hg19) chr10: 18,241,879-18,241,887). We cloned a 1.5 kb fragment of the 59 region of ZIP12 containing this HRE into the luciferase reporter vector, pGL4.10 ( Fig. 2d) . Human pulmonary vascular smooth muscle cells transfected with the ZIP12 HRE reporter vector demonstrated significantly increased luciferase activity after exposure to hypoxia, while the luciferase activity of cells transfected with the mutant HRE vector (a substitution of the 59-ACGTG-39 motif by 59-AGCAG-39; Fig. 2d ) remained at basal normoxia levels (Fig. 2e ). Chromatin immunoprecipitation (ChIP) followed by quantitative PCR (qPCR) confirmed the enrichment of both HIF-1a and HIF-2a bound to this ZIP12 HRE after hypoxia exposure (Fig. 2f) .
We then explored the contribution of ZIP12 to the regulation of intracellular zinc levels in human pulmonary vascular smooth muscle cells. Intracellular labile zinc measured using a genetically encoded fluorescence resonance energy transfer (FRET)-based zinc probe, eCALWY-4 (ref. 10) , exhibited a striking increase in cells exposed to hypoxia for 48 h, which was markedly reduced by inhibiting ZIP12 expression with a targeted short interfering (si)RNA ( Fig. 3a-e) . Inhibition of ZIP12 expression with siRNA also inhibited hypoxiainduced pulmonary vascular smooth muscle cell proliferation (Fig. 3f) . ZIP12 siRNA transfection did not affect intracellular zinc levels or proliferation in normoxia (Extended Data Fig. 4c-f ). These data suggest that disrupted ZIP12 expression exerts a direct effect on pulmonary vascular cells in response to hypoxia and contributes to the resistant pulmonary hypertension phenotype exhibited in F344 strain.
To provide direct genetic confirmation that disrupted ZIP12 expression attenuates the pulmonary vascular response to hypoxia, we employed zinc finger nuclease technology 11 to introduce mutations . This was inhibited by transfection with ZIP12 siRNA. TPEN-mediated Zn 21 chelation was used to derive maximum fluorescence and 100 mM ZnCl 2 in the presence of the Zn 21 ionophore and pyrithione (ZnPyr) was used to derive the minimum fluorescence. b, Representative traces showing the changes in fluorescence ratio of the eCALWY-4 probe. Steady-state fluorescence intensity ratio of citrine/ cerulean (R) was measured, then maximum and minimum ratios were determined to calculate free Zn 21 concentration using the formula
for eCALWY-4 is 630 pM, the maximum ratio (R max ) was obtained upon intracellular zinc chelation with 50 mM TPEN and the minimum ratio (R min ) was obtained upon zinc saturation with 100 mM ZnCl 2 in the presence of the Zn2 1 ionophore pyrithione (5 mM) (ref. 10) . c, Quantification of intracellular zinc levels (n 5 10 each group). d, Chronic hypoxia (48 h) increases ZIP12 mRNA levels in HPASMCs, which is inhibited by Slc39a12 siRNA (n 5 5 per group). e, Representative immunoblot of ZIP12 demonstrating inhibition of hypoxia-stimulated ZIP12 protein expression by Slc39a12 siRNA in HPASMCs (n 5 3). f, ZIP12 siRNA inhibits hypoxia-induced proliferation in HPASMCs (n 5 5 per group, replicated twice). *P , 0.05, ***P , 0.001 compared with control group, #P , 0.05 compared with hypoxia group; scr, scrambled siRNA control.
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G2015 Macmillan Publishers Limited. All rights reserved in Slc39a12 in the hypoxia-susceptible WKY rat strain. A mutant line was generated containing a frame-shift resulting in a truncated ZIP12 protein with loss-of-function (Extended Data Fig. 5 ). Inter-cross of heterozygous animals generated homozygous (ZIP12
) and wild-type (WT) rats that were then exposed to hypoxia (10% O 2 ) for 2 weeks. ZIP12 2/2 rats demonstrated lower pulmonary artery pressures, reduced right ventricular hypertrophy and less vascular remodelling than WT rats (Fig. 4a-c (Fig. 4d, e) . Comparison of the ZIP12 2/2 response to hypoxia with the WKY and F344 parental strains revealed that mutation of Slc39a12 was responsible for about 50% of the resistance observed in the F344 strain, highlighting the importance of Slc39a12 as a hypoxiasusceptibility gene but also suggesting that other genes yet to be identified might also contribute.
Systemic blood pressure and cardiac output in the hypoxic ZIP12 2/2 rats was similar to that of WT rats (Extended Data Fig. 6e-g ), signifying that the reduced pulmonary artery pressures in the ZIP12
2/2 rat in chronic hypoxia is due to reduced pulmonary vascular resistance (PVR; mean pulmonary artery pressure 5 PVR 3 cardiac output). Both vascular tone and structural remodelling contribute to PVR, and increased pulmonary vascular tone precedes the structural changes. ZIP12 expression may increase PVR by increasing pulmonary vascular tone. Zinc thiolate signalling has been reported to mediate the constriction of pulmonary microvascular endothelial cells in acute hypoxia through activation of protein kinase C and inhibition of myosin light chain phosphatase, inducing stress fibre formation and endothelial cell contraction 12 .
We have shown that ZIP12-targeted siRNA attenuates stress fibre formation in human pulmonary vascular smooth muscle cells cultured in hypoxia (Extended Data Fig. 6h, i) . However, given the timedependent induction of ZIP12 expression in pulmonary vasculature by hypoxia, the main contribution of ZIP12 is likely to be in regulating the response to chronic rather than acute hypoxia. In further support of a direct effect on structural remodelling of pulmonary arterioles, we investigated angiogenesis ex vivo using pulmonary arteriole rings dissected from ZIP12 2/2 and WT rats. Vascular outgrowth from ZIP12 2/2 vessels in response to hypoxia was attenuated compared with vessels from WT rats (Extended Data Fig. 6j, k) .
The underlying mechanisms through which ZIP12 affects hypoxic responses remain to be defined. Excess intracellular zinc concentrations mediated by upregulation of ZIP family members have been observed in a variety of tumour tissues and linked to cell proliferation and survival [13] [14] [15] . Zinc is a structural component of a large variety of intracellular proteins, including enzymes and transcription factors. Zinc-binding motifs have been identified in drug targets for pulmonary hypertension, for example phosphodiesterase type 5 (PDE5) and histone deacetylases 16, 17 . Reduced ZIP12 expression and intracellular labile zinc levels would be expected to inhibit PDE5 activity 18 , and we have previously shown that PDE5 inhibition attenuated pulmonary vascular smooth muscle proliferation in culture 19 . Following on from our demonstration that ZIP12 is hypoxia inducible and a key regulator of the pulmonary vascular response to chronic alveolar hypoxia exposure, we examined lung ZIP12 expression in other presentations of pulmonary hypertension where tissue hypoxia is an important driver of pathology. Again, in contrast to healthy lungs, ZIP12 expression was clearly evident in lung tissues from chronic iron-deficient rats 20 and rats exposed to monocrotaline, as well as in patients with idiopathic pulmonary arterial hypertension (IPAH) 21 ( Fig. 4f) , prominent in the remodelled pulmonary vasculature as identified by co-staining with smooth muscle actin (Fig. 4g) . HIF activation in these tissues was confirmed by upregulation of carbonic anhydrase IX, a recognized HIF-regulated biochemical signature ); c, pulmonary arteriole muscularization (n 5 5 per group). ***P , 0.001 compared with normoxia WT group, #P , 0.05 compared with hypoxia WT group after one-way ANOVA followed by Bonferroni correction for multiple testing. d, ZIP12 was undetectable by western blot in hypoxic ZIP12 2/2 rats but increased in hypoxic WT (WKY) rats (n 5 3 per group). e, ZIP12 expression by immunohistochemistry of WT and ZIP12
2/2 rat lungs before and after hypoxia (2 weeks). f, ZIP12 expression in lungs from a chronic iron-deficient rat, monocrotaline (MCT) rat and a patient with IPAH. g, Double immunofluorescence demonstrates colocalization of ZIP12 and smooth muscle actin in the remodelled vessels from the patient with IPAH.
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G2015 Macmillan Publishers Limited. All rights reserved of tissue hypoxia 22 (Extended Data Fig. 7) . Interestingly, the F344 rat strain has previously been reported to exhibit some resistance to monocrotaline-induced pulmonary hypertension 23 ; this was recapitulated in the ZIP12 2/2 rat (Extended Data Fig. 8 ). These data signal a fundamental role for ZIP12 in the regulation of pulmonary vascular homeostasis in hypoxic stress, relevant to the pathogenesis of pulmonary hypertension beyond that associated with life in a low-oxygen atmosphere. The current treatments for pulmonary hypertension centre on the pharmacological manipulation of signalling mechanisms used by vasoactive factors and have limited therapeutic benefit. Our observations open a new avenue of research into the therapeutic potential of ZIP12 inhibition and suppressed excursions of intracellular free zinc as a novel strategy for preventing or treating pulmonary hypertension.
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Animals. Inbred Wistar-Kyoto (WKY, Charles River) and Fischer 344 rats (F344, Harlan) were used as original strains. Animals were maintained at a constant temperature (20-22 uC) with a 12-h on/12-h off light cycle, with food and water ad libitum. All experiments were conducted under the project licence PPL70/7425 in accordance with the UK Home Office Animals (Scientific Procedures) Act 1986. To ascertain the pulmonary artery pressure phenotype, male rats (WKY, F344, congenic and sub-congenic strains, ZIP12 transgenic rats) aged 10-12 weeks were studied in batches, with the parental WKY strain included as an internal control in each batch studied. Sample sizes were chosen on the basis of experience of pulmonary artery pressure variation in the parental strains. A sample size of at least n 5 5 per group was predicted to detect a difference in mean pulmonary arterial pressure 3 of 5 mm Hg (SD 5 3) with 95% power with 95% confidence. Additional animals were studied to obtain sufficient tissue for supportive analyses. Generation of congenic and sub-congenic strains. To investigate the involvement of the chromosome 17 QTL in the pulmonary hypertension (PH) phenotype, we introgressed the F344 chromosome QTL segment into the WKY genetic background by repeated backcrossing 2 . We produced a congenic rat strain, R47A (WKY.F344-D17Got91/D17Rat51), which contains 15 Mbp from the F344 donor region that maps to the distal end of the QTL on the WKY background.
Subsequently, we generated three sub-congenic strains: Sub-A (WKY.F344-D17Got91/D17Rat47), Sub-B (WKY.F344-D17Rat47/D17Rat51) and Sub-C (WKY.F344-D17Rat131/D17Rat51). These three recombination events divided the R47A congenic interval into three smaller and overlapping sub-congenic intervals (Extended Data Fig. 1 ). Microsatellite genotyping of congenic rats. Congenic and sub-congenic rats were genotyped using simple sequence length polymorphism markers (Extended Data Table 2 ). To reduce the unknown regions between the markers, rats were also genotyped using primers specifically designed to amplify known regions containing insertions or deletions in one of the two parental strains (Extended Data Table 2 ). Genomic DNA was isolated from rat ear clippings using hot sodium hydroxide and Tris (HotSHOT) extraction 24 . Forward primers were fluorescently labelled with 6-FAM. PCR products together with the fluorescent size marker (ROX 400HD, Applied Biosystems) were diluted in formamide and run on a 3730xl DNA Analyzer (Applied Biosystems). Results were analysed using GeneMapper version 3.7 software (Applied Biosystems). Illumina genome sequencing library preparations. Five micrograms of male WKY/Ncrl (two animals) and F344/Ncrl (one animal) rats were used to construct paired-end whole-genome libraries with 300-550 bp insert size. Genomic DNA was prepared by standard phenol chloroform extraction followed by treatment with DNase-free RNase. DNA quality was assessed by spectrophotometry (260/ 280 and 260/230) and gel electrophoresis before library construction. Genomic DNA was sheared for 90 s (Covaris S2, KBioscience), using 10% duty cycle, 5 intensity and 200 cycles per burst. The shearing efficiency was assessed by Qubit 2.0 fluorometer measurements (Life Technologies) and gel electrophoresis. The library was prepared as recommended (Illumina Genomic DNA sample prep kit protocol) with nine cycles of PCR amplification (Illumina). Constructed libraries were assessed with an Agilent 2100 bioanalyser using an HS DNA assay (Agilent Technologies) and quantified using a KAPA Illumina SYBR Universal Lib QPCR kit (Anachem). The resulting libraries were sequenced on an Illumina HiSeq2000 following the manufacturer's instructions. Polymorphisms were confirmed by capillary sequencing. Generation and genotyping of WKY.Slc39a12 1/2 and Slc39a12 2/2 rats. CompoZr Custom Zinc Finger Nucleases targeting the rat Slc39a12 gene were designed and purchased from Sigma-Aldrich (Extended Data Fig. 3 ). Pronuclei from fertilized WKY oocytes were microinjected with ZFN mRNA (2 ng ml
21
). Three out of eleven pups were positive for Slc39a12 mutations, as revealed by Cel-I surveyor assay and gene sequencing 11 . One pup (mutant 77) hosted a stop codon 15 amino acids from the ZFN-binding site, resulting in a truncated protein of 490 amino acids (54 kDa), 198 amino acids smaller than the WT protein, and introduced a sequence coding for 59-ATTTAAAT-39, a binding site for the SwaI restriction enzyme. Mutant 77 was selected as a founder to mate with a WKY female. Pups were genotyped by amplifying DNA and digesting with SwaI. The primers used to amplify the region of interest were forward 59-GCAATG-GTTTTCCACAGTGA-39 and reverse 59-GCGCACTGAGGCTTTAAGAA-39. Pulmonary hypertension phenotyping. Pulmonary hypertension was induced by placing animals in a normobaric hypoxic chamber (FIO 2 5 10%) for 2 weeks or by subcutaneous injection of monocrotaline (60 mg kg
; Sigma-Aldrich). The experiments were not randomized. All studies were performed using the same equipment and all haemodynamic measurements were made by the same two operators. The operators were blinded to the genetic status of animals, which was confirmed after phenotyping. All histological assessments were made by two observers blinded to genetic status of the animals. At the end of each experimental period, animals were weighed and anaesthetized (Hypnorm 1 ml kg 21 intramuscularly; Mydazolam 0.8 ml kg 21 intraperitoneally). Pulmonary arterial pressure was measured with a pre-curved catheter inserted through the right jugular vein. Systemic blood pressure was assessed via carotid artery cannulation. Cardiac output was measured by thermodilution. PVR was calculated using the standard equation, PVR 5 mean pulmonary artery pressure/cardiac output. All data were recorded with a PowerLab Data Acquisition system (AD Instruments) and analysed using LabChart 7 software.
The animals were then killed and the heart dissected, and individual chamber weights recorded. The ratio of right ventricle to left ventricle plus the septum mass was calculated as the right ventricle hypertrophy index. Some collected tissues were snap frozen in liquid nitrogen and stored at 280 uC for further biochemical measurements. The left lung was fixed by inflation with 10% formalin in phosphate-buffered saline, embedded in paraffin and sectioned for histology. Transverse rat lung sections were processed for elastic van Gieson staining. Peripheral vessels less than 100 mm in diameter were counted at 340 magnification objective, and pulmonary vascular remodelling was expressed as the proportion of vessels with double elastic lamina (.75% of the circumference as fully muscularized, 25-75% as partly muscularized) to total vessels counted. Counting was performed twice by observers blinded to treatment. Ex vivo angiogenesis assay of pulmonary arteriole. Angiogenesis assay of arterial rings was performed as previously described 25 . Pulmonary arterioles (first and second order) were dissected from rat lungs viewed under the microscope. One millimetre sections were placed in matrigel (50 ml per well) in a 96-well plate, allowed to gel for 30 min at room temperature (20 uC), then incubated for up to 6 days with endothelial cell culture medium MV2 with 5% fetal calf serum (PromoCell). On days 3, 4, 5 and 6, the length of the longest sprouts was measured under the microscope (34 objective). On day 6, fluorescent images of the arteriole ring were taken by staining the tissue with calcein (Invitrogen) for 15 min at 37 uC. Anti-ZIP12 antibody production. An antibody raised against the last five amino acids at the C terminus of both the human and the rat ZIP12 protein was produced in rabbits following previous methodology 26 . Rabbits were immunized with synthetic peptides conjugated to keyhole limpet haemocyanin ([CYS(KLH)]QNIKI). Peptide sequence was confirmed to be ZIP12 specific using RStudio. Immunized rabbit serum containing anti-ZIP12 antibody specificity was confirmed by immunoblotting with rat lung lysates or human pulmonary smooth muscle cells. A single band at about 70 kDa was visible in the immunoblots. Lung sections were immunostained with rabbit anti-ZIP12 (1:1,000), Ki67 (1:50; Thermo Scientific) and rabbit anti-CAIX (1:100) antibodies. For immunohistochemistry, horseradish-peroxidase-conjugated secondary anti-rabbit antibody (1:200) was used. Double immunofluorescence with anti-aSMA (1:100) was performed using fluorescence secondary antibodies, anti-mouse Alexa 488 and anti-rabbit Alexa 568 (1:2,000, Invitrogen). Images (green for ZIP12 and red for aSMA) were detected under Leica confocal microscope (TCS SP2 AOBS). HPASMC culture. HPASMCs from PromoCell and Lonza were grown in human smooth muscle cell growth medium 2 (PromoCell). All commercial cell lines were tested for mycoplasma contamination. The cells were cultured under normal oxygen tension (20% O 2 , 5% CO 2 ) or exposed to hypoxia (2% O 2 , 5% CO 2 , 92% N 2 ) for 48-72 h. A bromodeoxyuridine (BrdU) cell proliferation assay (Millipore) was used to assess cell proliferation following the manufacturer's conditions. ZIP12 siRNA transfection. Cells were transfected overnight with 50 pmol siRNA against ZIP12 (s8397, Ambion), or negative siRNA (4390844, Ambion) as a control, using Lipofectamine RNAiMAX (Invitrogen Life Technologies) according to the manufacturer's conditions. Quantification of actin fibre formation. Cells were cultured on plastic coverslips (Nunc), transfected with scrambled or ZIP12 siRNA and exposed to hypoxia as described previously. After exposure for 48 h, cells were fixed with 4% formaldehyde solution in phosphate buffered saline for 10 min at room temperature. Cells were then incubated with Alexa-568-conjugated phalloidin (1/200; Invitrogen) for F-actin detection by confocal microscopy. Sequential xyz-sections (approximately 12 sections of 1 mm 2 per view) were obtained and three-dimensional images were reconstructed. Quantification of actin stress fibres was determined by volume rendering in Image-J. Actin volume per cell was expressed as the fold increase from normoxic control (value set at 1). Quantification of zinc concentration by FRET measurement. Cells on coverslips were washed twice in Krebs-HEPES-bicarbonate (KHB) buffer (140 mM NaCl, 3.6 mM KCl, 0.5 mM NaH 2 PO 4 , 0.2 mM MgSO 4 , 1.5 mM CaCl 2 , 10 mM LETTER RESEARCH HEPES, 25 mM NaHCO 3 ), which was warmed, bubbled with 95% O 2 /5% CO 2 , set to pH 7.4 and contained 3 mM glucose. Imaging of zinc using eCALWY sensors was performed as optimized before 10, 27 . Briefly, cells were maintained at 37 uC throughout with a heating stage (MC60, LINKAM, Scientific Instruments), and KHB buffer was perfused (1.5-2 ml min
) with additions as stated in the figures. Images were captured at 433 nm monochromatic excitation wavelength (Polychrome IV, Till Photonics) using an Olympus IX-70 wide-field microscope with a 340/1.35 numerical aperture oil immersion objective and a Zyla sCMOS camera (Andor Technology) controlled by Micromanager software 28 . Acquisition rate was 20 images per minute. Emitted light was split and filtered by a Dual-View beam splitter (Photometrics) equipped with a 505dcxn dichroic mirror and two emission filters (Chroma Technology D470/24 for cerulean and D535/30 for citrine).
Image analysis used ImageJ software 29 with a homemade macro, and the fluorescence emission ratios were derived after subtracting background. Steady-state fluorescence intensity ratio of citrine/cerulean (R) was measured, then maximum and minimum ratios were determined to calculate free Zn 21 concentrations using the following formula:
The maximum ratio (R max ) was obtained upon intracellular zinc chelation with 50 mM TPEN and the minimum ratio (R min ) was obtained upon zinc saturation with 100 mM ZnCl 2 in the presence of the Zn 21 ionophore pyrithione (5 mM) (ref. 10). HIF-motif analysis and cloning. HOMER 9 was used to scan for HIF-1a and HIF2a recognition motifs in the region 2 kb upstream and 1.5 kb downstream of the ZIP12 transcription start site. Results with a HOMER score ,6.5 were discarded. A 59 region of ZIP12 gene containing these motif (HRE) (human (hg19) chromosome 10: positions 18,240,587-18,242,100) was cloned into the multicloning site of pGL4.10, which encodes the luciferase reporter gene luc2, by Gibson Assembly (NEB, E2611S). Three nucleotide substitutions in the core of the predicted HIF1/2a-binding site motif were created by site-mutagenic PCR to produce a disabling mutant (Fig. 2d) . Transfection and luciferase assay. HPASMCs were seeded in 24-well plates at 70-80% confluence. Cells were transfected with 300 ng of each plasmid together with 2 ng of Renilla plasmid using Lipofectamine 2000 (Life Technologies), exposed to hypoxia and lysed according to the manufacturer's conditions. Luciferase activity was measured using Dual-Luciferase Reporter Assay Chemistry (Promega) as previously described 30 . Experiments were repeated in two cells lines, n 5 6 per line. ChIP and PCR. Specific protein-DNA interactions were examined by ChIP followed by qPCR (Chromatin Immunoprecipitation Assay Kit, Millipore). Protein-DNA crosslinks were achieved by fixation with 1% formaldehyde for 10 min at room temperature. DNA-protein complexes from 2 3 10 6 cells were sheared to lengths between 200 and 500 base pairs by sonicator (Bioruptor). The pre-cleared fragments were incubated with 10 mg of HIF-1a or HIF-2a specific antibody (Novus Biologicals), or without antibody (as a negative control) overnight, followed by immunoprecipitation by Protein A Agarose/Salmon Sperm DNA (50% Slurry). The crosslinks were reversed by heating at 65 uC overnight, followed by Proteinase K digestion at 45 uC for 2 h. DNA was then recovered with QIAquick PCR purification kit (Qiagen) for qPCR to prove affinity against ZIP12 promoter region (Fig. 2d ). Experiments were conducted in two separate cell lines (n 5 3 each) and gave the same result.
Quantitative PCR was performed as previously described in the methodology, using 1 ml of DNA sample, and using the forward primer 5-TTTCCCAAC CTGGGTCCTAT-3 and the reverse primer 5-AGCAGCCAAAAAGCTTGC TA-3. C terminus values were normalized compared with the values detected in the starting non-inmunoprecipitated DNA sample (input). Protein-DNA affinity was confirmed when normalized C terminus values were above the basal levels measured in the negative control. Quantitative PCR with reverse transcription. RNA was extracted from lungs using RNeasy Mini Kit (Qiagen). PCR was performed with an ABI 7500 Sequence Detection System (Applied Biosystems). Quantitative PCR was performed using a two-step protocol starting with complementary DNA (cDNA) synthesis using the ImProm-II Reverse Transcription System (Promega), followed by PCR using the Power SYBR Green PCR Master Mix (Applied Biosystems). A total of 100 ng of cDNA per sample was used. All samples were amplified using biological triplicates with two technical replicates per sample. The 7500 Sequence Detection System software (Applied Biosystems) was used to obtain C T values. Results were analysed using the comparative C T method 31 . Samples were normalized to a reference gene, Ubc (for rat samples) or Cyclophilin (for human cell samples), to account for cDNA loading differences. Western blot. Frozen rat tissues (lungs) and cell pellets were homogenized in RIPA buffer (50 mM tris-HCl, pH 8.0, 150 mM sodium chloride, 1.0% Igepal, 0.5% sodium deokycholate, 0.1% sodium dodecyl sulphate) (Sigma) supplemented with protease inhibitor (Roche). Western blotting used Mini-PROTEAN TGX Precast Gels (Bio-rad) following the manufacturer's suggestions. Blots were incubated for 1 h at room temperature with Anti-ZIP12 (1:10,000); Anti-HIF1a (1:1,000, Novus Biological) or Anti-HIF2a (1:1,000, Novus Biological). Proteins were detected by Clarity western ECL substrate (Bio-rad). Optical densities of individual bands were measured using ImageJ software and protein expressions were standardized with vinculin. Statistical analysis. Data are presented as mean 6 s.e.m. Data were tested for normality using a Kolmogorov-Smirnov test. All data were confirmed as normally distributed with similar variance between comparator groups. Data were analysed using one-way ANOVA followed by Bonferroni post-test adjustment for multiple comparisons or unpaired t-test. Graphpad Prism was used for all statistical analysis. Other bioinformatics analyses. The Ensembl database 32 was mined with the BioMart tool 33 to identify all transcribed elements in the confidence interval region. The search was limited to chromosome 17 between positions 85,072,475 and 93,347,758. PolyPhen analysis was used to predict the possible impact of described SNP on amino-acid substitution on the structure and function of a human protein 
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Extended Data Figure 6 | ZIP12 knockout attenuated hypoxia-induced pulmonary vascular remodelling. a, Representative lung sections from WT and ZIP12 2/2 rats 2 weeks after hypoxia exposure. Elastic van Gieson staining showing double elastic lamina (red arrow) in WT but single elastic laminae (blue arrow) in ZIP12 2/2 rats. b, Genetic disruption of ZIP12 in WKY rat attenuated pulmonary vascular remodelling after exposure for 2 weeks to a 10% O 2 atmosphere compared with WT rats (n 5 5 each group). *P , 0.01 compared with WT (percentage of fully muscularized vessels); ##P , 0.01, ###P , 0.001 compared with WT (percentage of non-muscularized vessels) after one-way ANOVA followed by Bonferroni's multiple comparison test. c, Ki67 staining showing reduced proliferation in hypoxic ZIP12 2/2 rat lungs compared with the WT strain. *P , 0.01 compared with WT. d, Representative sections from hypoxic WT and ZIP12 2/2 rats lungs showing differences in staining with the proliferation marker, Ki67. e-g, Genetic disruption of ZIP12 in WKY rat did not influence (e) systemic blood pressure (SBP) or (f) cardiac output (CO) but attenuated hypoxia-induced increases in (g) PVR (n 5 7 each group). Values are expressed as the mean 6 s.e.m. *P , 0.05, **P , 0.01 compared with normoxic rats, #P , 0.05 compared with WT hypoxic rats after one-way ANOVA followed by Bonferroni correction for multiple testing. h, ZIP12-targeted siRNA inhibition attenuates stress fibre formation in HPASMCs in hypoxia (n 5 5 each group). **P , 0.01 compared with normoxia control group, #P , 0.05 compared with hypoxia control group. i, Representative pictures of actin stress fibre in HPASMCs. j, Ex vivo angiogenesis studies demonstrated that vascular outgrowth from ZIP12 2/2 pulmonary vessels in response to hypoxia was attenuated compared with vessels from WT rats (n 5 12 each group, 2 rings per rat, 6 ZIP12
2/2 and 6 WT rats). *P , 0.05 compared with normoxia WT group; #P , 0.05, ##P , 0.01 and ###P , 0.001 compared with hypoxia ZIP12 2/2 group. k, Representative pictures of pulmonary arteriole ring outgrowth at day 6.
